Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data

Jennifer G. Andrews, Molly M. Lamb, Kristin Conway, Natalie Street, Christina Westfield, Emma Ciafaloni, Dennis Matthews, Christopher M Cunniff, Shree Pandya, Deborah J. Fox

Research output: Contribution to journalArticle

Abstract

Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are historically divided into the more severe Duchenne (DMD) and milder Becker (BMD) muscular dystrophy phenotypes. Classification is important for research and clinical care. The purpose of this study was to describe a multi-variable approach to classifying cases from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) and to assess the accuracy of the diagnostic classification scheme. We used age at loss of mobility, molecular testing results, and age at symptom onset to classify cases as having DMD or BMD and to assess sensitivity and specificity. Mobility status showed low sensitivity and high specificity for predicting DMD (65.5% and 99.3%, respectively) and BMD (62.8% and 97.7%, respectively) phenotypes. Molecular testing showed 90.9% sensitivity and 66.4% specificity for DMD; 76.3% sensitivity and 90.0% specificity for BMD. Age of onset predicted DMD with sensitivity of 73.9% and specificity of 69.0%; BMD had 99.7% specificity and 36.7% sensitivity. Mobility status, molecular test results, and age at symptom onset are important but inconsistent measures for accurately classifying individuals into DMD or BMD phenotypes. These results have implications for prognosis in newly diagnosed individuals and for classifying phenotype in clinical trials.

Original languageEnglish (US)
Pages (from-to)481-495
Number of pages15
JournalJournal of Neuromuscular Diseases
Volume5
Issue number4
DOIs
StatePublished - Jan 1 2018
Externally publishedYes

Fingerprint

Duchenne Muscular Dystrophy
Medical Records
Phenotype
Sensitivity and Specificity
Age of Onset
Muscular Dystrophies
Muscle Weakness
Research
Clinical Trials
Mutation

Keywords

  • Becker
  • diagnostic accuracy
  • Duchenne
  • dystrophinopathy
  • Muscular dystrophies
  • phenotype

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Andrews, J. G., Lamb, M. M., Conway, K., Street, N., Westfield, C., Ciafaloni, E., ... Fox, D. J. (2018). Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data. Journal of Neuromuscular Diseases, 5(4), 481-495. https://doi.org/10.3233/JND-180306

Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data. / Andrews, Jennifer G.; Lamb, Molly M.; Conway, Kristin; Street, Natalie; Westfield, Christina; Ciafaloni, Emma; Matthews, Dennis; Cunniff, Christopher M; Pandya, Shree; Fox, Deborah J.

In: Journal of Neuromuscular Diseases, Vol. 5, No. 4, 01.01.2018, p. 481-495.

Research output: Contribution to journalArticle

Andrews, JG, Lamb, MM, Conway, K, Street, N, Westfield, C, Ciafaloni, E, Matthews, D, Cunniff, CM, Pandya, S & Fox, DJ 2018, 'Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data', Journal of Neuromuscular Diseases, vol. 5, no. 4, pp. 481-495. https://doi.org/10.3233/JND-180306
Andrews, Jennifer G. ; Lamb, Molly M. ; Conway, Kristin ; Street, Natalie ; Westfield, Christina ; Ciafaloni, Emma ; Matthews, Dennis ; Cunniff, Christopher M ; Pandya, Shree ; Fox, Deborah J. / Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data. In: Journal of Neuromuscular Diseases. 2018 ; Vol. 5, No. 4. pp. 481-495.
@article{2ea6a65330384c1a8774f7c94b258b9b,
title = "Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data",
abstract = "Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are historically divided into the more severe Duchenne (DMD) and milder Becker (BMD) muscular dystrophy phenotypes. Classification is important for research and clinical care. The purpose of this study was to describe a multi-variable approach to classifying cases from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) and to assess the accuracy of the diagnostic classification scheme. We used age at loss of mobility, molecular testing results, and age at symptom onset to classify cases as having DMD or BMD and to assess sensitivity and specificity. Mobility status showed low sensitivity and high specificity for predicting DMD (65.5{\%} and 99.3{\%}, respectively) and BMD (62.8{\%} and 97.7{\%}, respectively) phenotypes. Molecular testing showed 90.9{\%} sensitivity and 66.4{\%} specificity for DMD; 76.3{\%} sensitivity and 90.0{\%} specificity for BMD. Age of onset predicted DMD with sensitivity of 73.9{\%} and specificity of 69.0{\%}; BMD had 99.7{\%} specificity and 36.7{\%} sensitivity. Mobility status, molecular test results, and age at symptom onset are important but inconsistent measures for accurately classifying individuals into DMD or BMD phenotypes. These results have implications for prognosis in newly diagnosed individuals and for classifying phenotype in clinical trials.",
keywords = "Becker, diagnostic accuracy, Duchenne, dystrophinopathy, Muscular dystrophies, phenotype",
author = "Andrews, {Jennifer G.} and Lamb, {Molly M.} and Kristin Conway and Natalie Street and Christina Westfield and Emma Ciafaloni and Dennis Matthews and Cunniff, {Christopher M} and Shree Pandya and Fox, {Deborah J.}",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JND-180306",
language = "English (US)",
volume = "5",
pages = "481--495",
journal = "Journal of Neuromuscular Diseases",
issn = "2214-3599",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Diagnostic accuracy of phenotype classification in duchenne and becker muscular dystrophy using medical record data

AU - Andrews, Jennifer G.

AU - Lamb, Molly M.

AU - Conway, Kristin

AU - Street, Natalie

AU - Westfield, Christina

AU - Ciafaloni, Emma

AU - Matthews, Dennis

AU - Cunniff, Christopher M

AU - Pandya, Shree

AU - Fox, Deborah J.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are historically divided into the more severe Duchenne (DMD) and milder Becker (BMD) muscular dystrophy phenotypes. Classification is important for research and clinical care. The purpose of this study was to describe a multi-variable approach to classifying cases from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) and to assess the accuracy of the diagnostic classification scheme. We used age at loss of mobility, molecular testing results, and age at symptom onset to classify cases as having DMD or BMD and to assess sensitivity and specificity. Mobility status showed low sensitivity and high specificity for predicting DMD (65.5% and 99.3%, respectively) and BMD (62.8% and 97.7%, respectively) phenotypes. Molecular testing showed 90.9% sensitivity and 66.4% specificity for DMD; 76.3% sensitivity and 90.0% specificity for BMD. Age of onset predicted DMD with sensitivity of 73.9% and specificity of 69.0%; BMD had 99.7% specificity and 36.7% sensitivity. Mobility status, molecular test results, and age at symptom onset are important but inconsistent measures for accurately classifying individuals into DMD or BMD phenotypes. These results have implications for prognosis in newly diagnosed individuals and for classifying phenotype in clinical trials.

AB - Dystrophinopathies are caused by mutations in DMD resulting in progressive muscle weakness. They are historically divided into the more severe Duchenne (DMD) and milder Becker (BMD) muscular dystrophy phenotypes. Classification is important for research and clinical care. The purpose of this study was to describe a multi-variable approach to classifying cases from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) and to assess the accuracy of the diagnostic classification scheme. We used age at loss of mobility, molecular testing results, and age at symptom onset to classify cases as having DMD or BMD and to assess sensitivity and specificity. Mobility status showed low sensitivity and high specificity for predicting DMD (65.5% and 99.3%, respectively) and BMD (62.8% and 97.7%, respectively) phenotypes. Molecular testing showed 90.9% sensitivity and 66.4% specificity for DMD; 76.3% sensitivity and 90.0% specificity for BMD. Age of onset predicted DMD with sensitivity of 73.9% and specificity of 69.0%; BMD had 99.7% specificity and 36.7% sensitivity. Mobility status, molecular test results, and age at symptom onset are important but inconsistent measures for accurately classifying individuals into DMD or BMD phenotypes. These results have implications for prognosis in newly diagnosed individuals and for classifying phenotype in clinical trials.

KW - Becker

KW - diagnostic accuracy

KW - Duchenne

KW - dystrophinopathy

KW - Muscular dystrophies

KW - phenotype

UR - http://www.scopus.com/inward/record.url?scp=85055618102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055618102&partnerID=8YFLogxK

U2 - 10.3233/JND-180306

DO - 10.3233/JND-180306

M3 - Article

VL - 5

SP - 481

EP - 495

JO - Journal of Neuromuscular Diseases

JF - Journal of Neuromuscular Diseases

SN - 2214-3599

IS - 4

ER -